Figure 1
Figure 1. Genomic instability (based on microsatellite analysis) in oral and nasal mucosa. (Top) Percent of subjects with genomic instability detected in oral and nasal specimens among the following subjects: Healthy individuals, Chemotherapy-only controls (received chemotherapy but no transplantation), Autologous HCT controls, Short-term survivors of allogeneic HCT (7-98 days), and Long-term survivors of allogeneic HCT (4-22 years). (Bottom) Number of microsatellite markers showing instability in long-term allogeneic HCT survivors with and without history of oral cGVHD. Black horizontal lines represent the median number of microsatellite markers showing instability. Significance of difference calculated for the 2 groups was P = .007 in univariate analysis (Mann-Whitney-Wilcoxon rank sum test) and P = .005 in multivariate analysis (multinomial logistic regression).

Genomic instability (based on microsatellite analysis) in oral and nasal mucosa. (Top) Percent of subjects with genomic instability detected in oral and nasal specimens among the following subjects: Healthy individuals, Chemotherapy-only controls (received chemotherapy but no transplantation), Autologous HCT controls, Short-term survivors of allogeneic HCT (7-98 days), and Long-term survivors of allogeneic HCT (4-22 years). (Bottom) Number of microsatellite markers showing instability in long-term allogeneic HCT survivors with and without history of oral cGVHD. Black horizontal lines represent the median number of microsatellite markers showing instability. Significance of difference calculated for the 2 groups was P = .007 in univariate analysis (Mann-Whitney-Wilcoxon rank sum test) and P = .005 in multivariate analysis (multinomial logistic regression).

Close Modal

or Create an Account

Close Modal
Close Modal